Predicting abnormal coagulation in ischemic stroke: Reducing delay in rt-PA use
- 14 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (9) , 1665-1667
Abstract
Normal prothrombin time (PT) and partial thromboplastin time (PTT) are recommended for administration of recombinant tissue-plasminogen activator (rt-PA) in stroke, but waiting for results can delay use. We examined the charts of 365 stroke patients to assess predetermined risk factors associated with elevated PT/PTT. Elevated PT/PTT can be predicted in patients taking warfarin or heparin/heparinoid or on hemodialysis, according to emergency department triage, with 100% sensitivity and 94.7% specificity. These results could be applied to rt-PA candidates and reduce potential delays.Keywords
This publication has 4 references indexed in Scilit:
- The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)Stroke, 2005
- Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsThe Lancet, 2004
- Evaluation of Guidelines for Ordering Prothrombin and Partial Thromboplastin TimesAcademic Emergency Medicine, 2002
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995